Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 11

Results For "R-Pharm"

492 News Found

CPHI & PMEC India 2026 expand to dual venues in Delhi NCR
News | April 30, 2026

CPHI & PMEC India 2026 expand to dual venues in Delhi NCR

CPHI India from 23–25 November 2026 at Yashobhoomi (India International Convention and Expo Centre), while PMEC India from 24–26 November 2026 at India Expo Mart


Aurigene bets big on CRDMO expansion with $100 million outlay
News | April 28, 2026

Aurigene bets big on CRDMO expansion with $100 million outlay

Deploys $40 million in Hyderabad; advances APIs, peptides, and global small molecule capabilities


Vision 360 brings academia, industry together to advance ophthalmic therapies
Healthcare | April 25, 2026

Vision 360 brings academia, industry together to advance ophthalmic therapies

VESCOP, ENTOD Pharmaceuticals, and APTI-MSB host the event to bridge lab-to-clinic gap in eye care


IPC signs MoUs with PMBI, NIPER Hajipur to boost drug quality, pharmacovigilance and research collaboration
Policy | April 25, 2026

IPC signs MoUs with PMBI, NIPER Hajipur to boost drug quality, pharmacovigilance and research collaboration

The agreements aim to strengthen medicine quality, patient safety and pharmaceutical research in India


Merck & Google Cloud ink $1 billion AI deal to build “Agentic” pharma future
Digitisation | April 24, 2026

Merck & Google Cloud ink $1 billion AI deal to build “Agentic” pharma future

The collaboration will roll out an “agentic” AI platform across Merck’s research & development, manufacturing, commercial, and corporate operations


PAGE, 8chili Inc. collaborate to scale AI-powered pharma training ecosystem
Digitisation | April 23, 2026

PAGE, 8chili Inc. collaborate to scale AI-powered pharma training ecosystem

Platform integrates VR simulations and AI-driven coaching to build job-ready skills in pharma manufacturing


ProBioGen appoints Dr Simon Johannes Bulling as its new Chief Operating Officer
People | April 22, 2026

ProBioGen appoints Dr Simon Johannes Bulling as its new Chief Operating Officer

Bulling brings extensive experience across the biopharma and CDMO landscape, with leadership roles spanning both drug substance and drug product operations


Asahi Kasei pushes into human trials with new autoimmune drug candidate
Clinical Trials | April 22, 2026

Asahi Kasei pushes into human trials with new autoimmune drug candidate

The study is being conducted through its Japan-based pharmaceutical arm, Asahi Kasei Therapeutics Corp


Asahi Kasei seals Aicuris acquisition to bolster infectious disease pharma push
Biopharma | April 22, 2026

Asahi Kasei seals Aicuris acquisition to bolster infectious disease pharma push

The deal the group says marks a decisive push deeper into severe infectious diseases and the build-out of a global specialty pharmaceuticals platform


Orbicular's partner secures tentative U.S. ANDA approval for a generic version of Ozempic
Drug Approval | April 21, 2026

Orbicular's partner secures tentative U.S. ANDA approval for a generic version of Ozempic

OneSource is the contract development and manufacturing organization (CDMO) partner for this product